Search Results 521-530 of 16846 for Antagonist

1. https://www.mayoclinic.org/chinese_organization_concepts.xml

2. Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production - Mayo Clinic

   Mifepristone or other GR antagonists within 5 half-lives of these medications 4. Adrenostatic medications within 5 half-lives of these medications - History ...

3. https://www.mayoclinic.org/arabic_organization_concepts.xml

4. A Long-term Active Treatment Study Of Mongersen (GED-0301) In Subjects With Crohn's Disease - Mayo Clinic

   Subject has initiated biologic agents, such as TNF-α blockers or integrin antagonists. Subject is pregnant or breastfeeding. Subject has developed a known ...

5. A Study Of Lofexidine For Rapid Opioid Tapering In Adults - Mayo Clinic

   ... antagonists, tricyclic antidepressants, benzodiazepines, and selective serotonin reuptake inhibitors. Patients may be excluded for use of other medications ...

6. Long Term Follow-Up of Subjects Exposed to GSK3377794 - Mayo Clinic

   About this study. The purpose of this long-term, followup study is to evaluate subjects who have, during the interventional study, received GSK3377794 ...

7. A Study To Evaluate The Effectiveness, Safety, And Tolerability Of BOS-589 In The Treatment Of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

   5-hydroxytriptamine (5-HT)3 or 5‑HT4 receptor antagonists (e.g., alosetron, ondansetron, or ramosetron);; Eluxadoline;; Any of the strong inhibitors of P ...

8. A Study to Evaluate the Effectiveness and Safety of Ralinepag To Improve Treatment Outcomes in Peripheral Arterial Hypertension (PAH) Patients - Mayo Clinic

   If on PAH-specific background oral therapy, subject is on stable therapy with either an endothelin receptor antagonist (ERA) and/or a phosphodiesterase type ...

9. A Study to Evaluate the Safety and Effectiveness of Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients with Crohn's Disease - Mayo Clinic

   ... antagonist or vedolizumab or ustekinumab, or having documented intolerance ... TNFα antagonists: Infliximab: at least 14 weeks treatment at the ...

10. A Study to Evaluate the Effectiveness and Safety of RalinEpag for Improving Treatment Outcomes in PAH Patients - Mayo Clinic

    an endothelin receptor antagonist (ERA) and/or a phosphodiesterase type 5 inhibitor (PDE5-I) or a soluble guanylate cyclase (sGC) stimulator. 8. Has a 6MWD ...